181 related articles for article (PubMed ID: 32931592)
1. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil.
Maffazioli GDN; Lopes CP; Heinrich-Oliveira V; Lobo RA; Hayashida SAY; Soares JM; Maciel GAR; Baracat EC
Int J Gynaecol Obstet; 2020 Dec; 151(3):383-391. PubMed ID: 32931592
[TBL] [Abstract][Full Text] [Related]
2. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.
Huang J; Ni R; Chen X; Huang L; Mo Y; Yang D
Reprod Biol Endocrinol; 2010 Nov; 8():142. PubMed ID: 21083920
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors.
Rocha MP; Marcondes JA; Barcellos CR; Hayashida SA; Curi DD; da Fonseca ÂM; Bagnoli VR; Baracat EC
Gynecol Endocrinol; 2011 Oct; 27(10):814-9. PubMed ID: 20807166
[TBL] [Abstract][Full Text] [Related]
6. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome.
Pantasri T; Vutyavanich T; Sreshthaputra O; Srisupundit K; Piromlertamorn W
J Med Assoc Thai; 2010 Apr; 93(4):406-12. PubMed ID: 20462081
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
Moran LJ; Misso ML; Wild RA; Norman RJ
Hum Reprod Update; 2010; 16(4):347-63. PubMed ID: 20159883
[TBL] [Abstract][Full Text] [Related]
9. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome in polycystic ovary syndrome.
Essah PA; Nestler JE
J Endocrinol Invest; 2006 Mar; 29(3):270-80. PubMed ID: 16682845
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
12. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome.
Kalra A; Nair S; Rai L
Indian J Med Sci; 2006 Nov; 60(11):447-53. PubMed ID: 17090865
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome.
El-Mazny A; Abou-Salem N; El-Sherbiny W; El-Mazny A
Int J Gynaecol Obstet; 2010 Jun; 109(3):239-41. PubMed ID: 20199774
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
15. Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.
Gambineri A; Pelusi C; Manicardi E; Vicennati V; Cacciari M; Morselli-Labate AM; Pagotto U; Pasquali R
Diabetes; 2004 Sep; 53(9):2353-8. PubMed ID: 15331545
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
[TBL] [Abstract][Full Text] [Related]
17. Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome.
Kim JJ; Hwang KR; Choi YM; Moon SY; Chae SJ; Park CW; Kim HO; Choi DS; Kwon HC; Kang BM; Lee BS; Cho SH; Kim TJ; Kim T; Kim MJ; Park HY
Fertil Steril; 2014 May; 101(5):1424-30. PubMed ID: 24613538
[TBL] [Abstract][Full Text] [Related]
18. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.
Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
Eur J Endocrinol; 2014 May; 170(5):727-39. PubMed ID: 24591551
[TBL] [Abstract][Full Text] [Related]
19. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome.
Vrbikova J; Dvorakova K; Grimmichova T; Hill M; Stanicka S; Cibula D; Bendlova B; Starka L; Vondra K
Clin Chem Lab Med; 2007; 45(5):639-44. PubMed ID: 17484627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
